Mallinckrodt Pharmaceuticals (MNK)
Quick facts
| Ticker | MNK (NYSE) |
|---|
Marketed products
- Cyanocobalamin Co 57 · Hematology
- Cholebrine · Other
Cholebrine works by binding to a specific target, although its exact mechanism of action is currently unknown. - IV Acetaminophen · Pain Management
Acetaminophen inhibits prostaglandin synthesis in the central nervous system to reduce pain and fever. - IV Acetaminophen (Treatment A) · Pain Management
Acetaminophen inhibits prostaglandin synthesis in the central nervous system to reduce pain and fever. - Oxycodone hydrochloride tablet 15 mg
- Repository Corticotropin Injection
- Phosphotope · Hematology
- Restoril · Neuroscience
- Xe 133 · Respiratory
Phase 3 pipeline
- COV155 · Neurology / Psychiatry
COV155 is a selective norepinephrine reuptake inhibitor that increases norepinephrine levels in the central nervous system. - COV795 · Immunology
COV795 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by increasing intracellular cAMP levels. - Fibrocaps · Other
- Gelatin sponge · Surgery/Hemostasis
Gelatin sponge is a hemostatic agent that absorbs blood and promotes clotting through physical absorption and platelet aggregation. - IK-3001 · Hematology
IK-3001 is an intravenous iron replacement therapy that replenishes depleted iron stores in patients with iron deficiency. - IV Control · Critical Care
IV Control is used to control the rate of intravenous medication administration. - Nitric Oxide plus Oxygen · Cardiovascular / Pulmonary
Nitric oxide gas combined with oxygen improves oxygenation and vasodilation in the lungs to reduce pulmonary hypertension and improve gas exchange. - PENNSAID Gel · Rheumatology / Pain Management
PENNSAID is a topical nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation at the site of application.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Mallinckrodt Pharmaceuticals
What is the ticker symbol for Mallinckrodt Pharmaceuticals?
Mallinckrodt Pharmaceuticals trades as MNK on the NYSE.
What are Mallinckrodt Pharmaceuticals's marketed drugs?
Top marketed products include Cyanocobalamin Co 57, Cholebrine, IV Acetaminophen, IV Acetaminophen (Treatment A), Oxycodone hydrochloride tablet 15 mg, Repository Corticotropin Injection.
What is Mallinckrodt Pharmaceuticals's pipeline?
Mallinckrodt Pharmaceuticals has 8 drugs in Phase 3, 1 in Phase 2, 2 in Phase 1. Late-stage candidates include COV155, COV795, Fibrocaps, Gelatin sponge.
Related
- Cyanocobalamin Co 57 · Hematology
- Cholebrine · Other
- IV Acetaminophen · Pain Management
- IV Acetaminophen (Treatment A) · Pain Management
- Oxycodone hydrochloride tablet 15 mg
- Sector hub: All tracked pharma companies
- Ticker: MNK · NYSE